Results 101 to 110 of about 5,721 (151)

Multiphasic Infarcts in a Young Brain Secondary to Thrombotic Thrombocytopenic Purpura: Looking Beyond the Usual Suspects. [PDF]

Ann Indian Acad Neurol
Thejas NJA, Chattopadhyay AP, Kenchiah R, Pendharkar H, Mahale RR, Mailankody P, Padmanabha H.   +6 more
europepmc   +1 more source

Thrombotic thrombocytopenic purpura in pregnancy: Lessons from a case series of three patients. [PDF]

J Int Med Res
Elkourashy SA, Mashhadi T, Al-Kuwari A, Al-Abdulla S, Sayed G.   +4 more
europepmc   +1 more source

Clusterin maintains hemostatic equilibrium by stabilizing VWF multimers in plasma.

Blood
Qiao Z, Cao Y, Su J, Lu S, Wei G, Jin S, Ding Q, Sun Y, Huo Y, Dong M, Luo J, Li P.   +11 more
europepmc   +1 more source

Late Onset of Congenital TTP: Case Presentation and Review of the Literature. [PDF]

Clin Med Insights Case Rep
Chatzisfetkos A, Bergmann C, Janssen U.
europepmc   +1 more source

Prediction of Functional Outcomes at Discharge Using Plasma Concentration of von Willebrand Factor Antigen at Admission in Hospitalized Patients with COVID-19. [PDF]

Ann Vasc Dis
Oki M, Yamasawa D, Goto S, Yanagi H, Manabe S, Kobayashi T, Tsuda A, Sato S, Morita S, Nakagawa Y, Oguma T, Asano K, Yamamoto N, Ozawa H, Goto S.   +14 more
europepmc   +1 more source

The complement factor B inhibitor iptacopan for relapsed and refractory immune thrombotic thrombocytopenic purpura. [PDF]

Thromb J
Zhou M, Li X, Wang R, Zhou H, Hou Y, Qin P, Ma S, Chen C.   +7 more
europepmc   +1 more source

A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura. [PDF]

Res Pract Thromb Haemost
Dierickx M, Groten S, Miranda M, Langerhorst P, van der Zwaan C, Mul E, Hoogendijk AJ, Voorberg J.   +7 more
europepmc   +1 more source

Endothelial Biomarkers and Cytokine Profiles: Signatures of Mortality in Severe COVID-19. [PDF]

Int J Mol Sci
van Staden QA, Meiring M, Hanekom HA, Nkuna V, Botes L, Smit FE.   +5 more
europepmc   +1 more source

Acquired Thrombotic Thrombocytopenic Purpura with a Poor Response to Treatment can be an Initial Manifestation of Occult Signet Ring Cell Carcinoma and other Malignancies. [PDF]

Eur J Case Rep Intern Med
Ahmad M, Alswij MA, Musleh M, Hamdan H, Alhusein Q.   +4 more
europepmc   +1 more source

Thrombotic thrombocytopenic purpura as a complication of pembrolizumab: a case report and literature Review. [PDF]

Ann Hematol
Palega G, Al-Rikabi IA, Kopaczek-Styczen M, Karlström C.   +3 more
europepmc   +1 more source